Kontafarma Clarifies Executive Title Error
Company Announcements

Kontafarma Clarifies Executive Title Error

Kontafarma China Holdings Ltd (HK:1312) has released an update.

Kontafarma China Holdings Limited has issued a clarification regarding an error in the title of Mr. Wang Feifei in their recent announcement. The correct title for Mr. Wang Feifei is ‘President’ rather than ‘Executive President’ as previously stated. The company confirms that apart from this correction, all other details in the original documents remain unchanged.

For further insights into HK:1312 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App